379 related articles for article (PubMed ID: 19473657)
1. Effects of fasudil on early atherosclerotic plaque formation and established lesion progression in apolipoprotein E-knockout mice.
Wu DJ; Xu JZ; Wu YJ; Jean-Charles L; Xiao B; Gao PJ; Zhu DL
Atherosclerosis; 2009 Nov; 207(1):68-73. PubMed ID: 19473657
[TBL] [Abstract][Full Text] [Related]
2. Effects of exercise training and RhoA/ROCK inhibition on plaque in ApoE-/- mice.
Matsumoto A; Manthey HD; Marsh SA; Fassett RG; de Haan JB; Rolfe BE; Coombes JS
Int J Cardiol; 2013 Aug; 167(4):1282-8. PubMed ID: 22525349
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947
[TBL] [Abstract][Full Text] [Related]
4. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
[TBL] [Abstract][Full Text] [Related]
5. Effect of S-aspirin, a novel hydrogen-sulfide-releasing aspirin (ACS14), on atherosclerosis in apoE-deficient mice.
Zhang H; Guo C; Zhang A; Fan Y; Gu T; Wu D; Sparatore A; Wang C
Eur J Pharmacol; 2012 Dec; 697(1-3):106-16. PubMed ID: 23085268
[TBL] [Abstract][Full Text] [Related]
6. Effects of rosuvastatin on cardiovascular morphology and function in an ApoE-knockout mouse model of atherosclerosis.
Grönros J; Wikström J; Brandt-Eliasson U; Forsberg GB; Behrendt M; Hansson GI; Gan LM
Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2046-53. PubMed ID: 18790840
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice.
Nencioni A; da Silva RF; Fraga-Silva RA; Steffens S; Fabre M; Bauer I; Caffa I; Magnone M; Sociali G; Quercioli A; Pelli G; Lenglet S; Galan K; Burger F; Vázquez Calvo S; Bertolotto M; Bruzzone S; Ballestrero A; Patrone F; Dallegri F; Santos RA; Stergiopulos N; Mach F; Vuilleumier N; Montecucco F
Thromb Haemost; 2014 Feb; 111(2):308-22. PubMed ID: 24196571
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice.
Wang YX; da Cunha V; Martin-McNulty B; Vincelette J; Li W; Choy DF; Halks-Miller M; Mahmoudi M; Schroeder M; Johns A; Light DR; Dole WP
Eur J Pharmacol; 2005 Apr; 512(2-3):215-22. PubMed ID: 15840407
[TBL] [Abstract][Full Text] [Related]
9. Effects of the factor Xa inhibitor, fondaparinux, on the stability of atherosclerotic lesions in apolipoprotein E-deficient mice.
Zuo P; Zhou Q; Zuo Z; Wang X; Chen L; Ma G
Circ J; 2015; 79(11):2499-508. PubMed ID: 26346031
[TBL] [Abstract][Full Text] [Related]
10. Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis.
Wang YX; Martin-McNulty B; da Cunha V; Vincelette J; Lu X; Feng Q; Halks-Miller M; Mahmoudi M; Schroeder M; Subramanyam B; Tseng JL; Deng GD; Schirm S; Johns A; Kauser K; Dole WP; Light DR
Circulation; 2005 May; 111(17):2219-26. PubMed ID: 15851596
[TBL] [Abstract][Full Text] [Related]
11. Effects of Shenlian extract on experimental atherosclerosis in ApoE-deficient mice based on ultrasound biomicroscopy.
Guo Y; Liu XC; Wang YJ; Li Q; Yang Q; Weng XG; Chen Y; Cai WY; Kan XX; Chen X; Huang HF; Zhu XX; Li YJ
BMC Complement Altern Med; 2016 Nov; 16(1):469. PubMed ID: 27846838
[TBL] [Abstract][Full Text] [Related]
12. Chronic administration of an oral Rho kinase inhibitor prevents the development of vasculogenic erectile dysfunction in a rat model.
Park K; Kim SW; Rhu KS; Paick JS
J Sex Med; 2006 Nov; 3(6):996-1003. PubMed ID: 17100932
[TBL] [Abstract][Full Text] [Related]
13. Micro-ultrasound imaging assessment of carotid plaque characteristics in apolipoprotein-E knockout mice.
Ni M; Zhang M; Ding SF; Chen WQ; Zhang Y
Atherosclerosis; 2008 Mar; 197(1):64-71. PubMed ID: 17870080
[TBL] [Abstract][Full Text] [Related]
14. Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment.
Johnson J; Carson K; Williams H; Karanam S; Newby A; Angelini G; George S; Jackson C
Circulation; 2005 Mar; 111(11):1422-30. PubMed ID: 15781753
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of rupture of established atherosclerotic plaques by treatment with apolipoprotein A-I.
Reimers GJ; Jackson CL; Rickards J; Chan PY; Cohn JS; Rye KA; Barter PJ; Rodgers KJ
Cardiovasc Res; 2011 Jul; 91(1):37-44. PubMed ID: 21354994
[TBL] [Abstract][Full Text] [Related]
16. Long-term administration of rho-kinase inhibitor ameliorates renal damage in malignant hypertensive rats.
Ishikawa Y; Nishikimi T; Akimoto K; Ishimura K; Ono H; Matsuoka H
Hypertension; 2006 Jun; 47(6):1075-83. PubMed ID: 16636194
[TBL] [Abstract][Full Text] [Related]
17. Effect of everolimus on pre-existing atherosclerosis in LDL-receptor deficient mice.
Beutner F; Brendel D; Teupser D; Sass K; Baber R; Mueller M; Ceglarek U; Thiery J
Atherosclerosis; 2012 Jun; 222(2):337-43. PubMed ID: 22446027
[TBL] [Abstract][Full Text] [Related]
18. A meprin inhibitor suppresses atherosclerotic plaque formation in ApoE-/- mice.
Gao P; Guo RW; Chen JF; Chen Y; Wang H; Yu Y; Huang L
Atherosclerosis; 2009 Nov; 207(1):84-92. PubMed ID: 19464686
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of anti-platelet therapies on atherosclerotic lesion formation assessed by phase-contrast X-ray CT imaging.
Takeda M; Yamashita T; Shinohara M; Sasaki N; Tawa H; Nakajima K; Momose A; Hirata K
Int J Cardiovasc Imaging; 2012 Jun; 28(5):1181-91. PubMed ID: 21688134
[TBL] [Abstract][Full Text] [Related]
20. Wide therapeutic time window for Rho-kinase inhibition therapy in ischemic brain damage in a rat cerebral thrombosis model.
Satoh S; Toshima Y; Hitomi A; Ikegaki I; Seto M; Asano T
Brain Res; 2008 Feb; 1193():102-8. PubMed ID: 18187127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
